Evidence map›Paper›PMID 27699025›Full record

ArticleMolecular and clinical oncology2016

Allogeneic stem cell transplantation in a blast-phase chronic myeloid leukemia patient with carbapenem-resistant

Bulent Kantarcioglu, Huseyin Saffet Bekoz, Fatih Erkam Olgun, Beytullah Cakal, Burak Arkan, Halil Turkoglu, Ali Mert, Deniz Sargin

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular and clinical oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Tricuspid Valve Infective Endocarditis Due toHawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health · 2019
    Article
  4. Thrombosis, Septic Emboli, and Multiple Abscesses Triggered byJournal of investigative medicine high impact case reports
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Bulent KantarciogluDivision of Hematology, Department of Internal Medicine, Istanbul Medipol University, 34214 Istanbul, Turkey.
Huseyin Saffet BekozDivision of Hematology, Department of Internal Medicine, Istanbul Medipol University, 34214 Istanbul, Turkey.
Fatih Erkam OlgunDepartment of Cardiology, Istanbul Medipol University, 34214 Istanbul, Turkey.
Beytullah CakalDepartment of Cardiology, Istanbul Medipol University, 34214 Istanbul, Turkey.
Burak ArkanDepartment of Cardiovascular Surgery, Istanbul Medipol University, 34214 Istanbul, Turkey.
Halil TurkogluDepartment of Cardiovascular Surgery, Istanbul Medipol University, 34214 Istanbul, Turkey.
Ali MertDepartment of Infectious Diseases and Clinical Microbiology, Istanbul Medipol University, 34214 Istanbul, Turkey.
Deniz SarginDivision of Hematology, Department of Internal Medicine, Istanbul Medipol University, 34214 Istanbul, Turkey.
Istanbul Medipol University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In chronic myeloid leukemia (CML), the occurrence of blastic transformation is rare. Treatment outcome is generally poor. Allogeneic stem cell transplantation (allo-SCT) is the only potentially curative treatment option for advanced-phase CML. Infections caused by carbapenem-resistant

Indexed as

allogeneic stem cell transplantationcarbapenem-resistant Klebsiella pneumoniaeinfective endocarditis

Identifiers

PMID27699025
PMCPMC5038443
OpenAlexW2511609433

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.